NDA Archives - Market Exclusive

Home Tags NDA

Here’s What The Latest Pain Therapeutics, Inc. (NASDAQ:PTIE) Update Means

Mark Collins - February 21, 2017

Here’s Our Take On Theravance Biopharma Inc (NASDAQ:TBPH) and GlaxoSmithKline plc...

Mark Collins - November 22, 2016

Here’s Our Take On The Latest ProQR Therapeutics NV (NASDAQ:PRQR) Release

Mark Collins - October 27, 2016

Here Are Two Dates To Keep An Eye On In Biotech...

Mark Collins - October 20, 2016

TherapeuticsMD Inc (NYSEMKT:TXMD)’s Other Candidate Could Be More Important Than Yuvvexy

Mark Collins - September 28, 2016

Looking Ahead To The Potentially Game Changing TESARO Inc (NASDAQ:TSRO) Data

Mark Collins - September 13, 2016

What Are Array Biopharma Inc (NASDAQ:ARRY)’s Chances Of PDUFA Success?

Mark Collins - September 2, 2016

What The Latest Data Means For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Mark Collins - August 30, 2016

Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (NASDAQ:ADMS) And Acorda...

Mark Collins - August 5, 2016

Aerie Pharmaceuticals Inc (NASDAQ:AERI) Is Finally Set For The Rhopressa NDA

David Zazoff - August 4, 2016

12 3 Page 1 of 3

EDITOR PICKS

Here’s What’s Moving Dynavax Technologies Corporation (NASDAQ:DVAX) And Tenax Therapeutics, Inc....

July 31, 2017

Here’s What’s Moving Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) and IntelliPharmaCeutics Intl Inc...

July 28, 2017

Here’s What Just Happened With Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)

July 27, 2017

This Small Nasdaq Hidden Gem May Have a $2.8B Drug

July 16, 2017

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: NDA